Matthias Peipp, PhDProfessor and Head of Research at Christian-Albrechts-University Kiel
Matthias Peipp received his PhD at the chair of genetics, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany in 2003. In 2004, he moved to the Christian-Albrechts-University of Kiel (Kiel, Germany), where he studied effector mechanisms mediated by human EGFR antibodies. In 2006, Matthias moved to the Division of Stem Cell Transplantation and Immunotherapy (Kiel, Germany) where he is heading the research division and a research group interested in antibody-based immunotherapy of cancer. In 2015 Matthias was awarded an endowed professorship “Mildred-Scheel-Professorship for experimental antibody-based cancer immunotherapy” funded by the German Cancer Aid. His current work is focused on antibody engineering to improve cancer immunotherapy.